Home Cart 0 Sign in  
X

[ CAS No. 4442-53-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4442-53-9
Chemical Structure| 4442-53-9
Chemical Structure| 4442-53-9
Structure of 4442-53-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4442-53-9 ]

Related Doc. of [ 4442-53-9 ]

Alternatived Products of [ 4442-53-9 ]

Product Details of [ 4442-53-9 ]

CAS No. :4442-53-9 MDL No. :MFCD00239415
Formula : C9H8O4 Boiling Point : -
Linear Structure Formula :- InChI Key :VCLSWKVAHAJSFL-UHFFFAOYSA-N
M.W : 180.16 Pubchem ID :78184
Synonyms :

Calculated chemistry of [ 4442-53-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 44.27
TPSA : 55.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 1.16
Log Po/w (MLOGP) : 0.66
Log Po/w (SILICOS-IT) : 1.5
Consensus Log Po/w : 1.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.96
Solubility : 1.96 mg/ml ; 0.0109 mol/l
Class : Very soluble
Log S (Ali) : -1.93
Solubility : 2.14 mg/ml ; 0.0119 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.8
Solubility : 2.84 mg/ml ; 0.0158 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.23

Safety of [ 4442-53-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4442-53-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4442-53-9 ]
  • Downstream synthetic route of [ 4442-53-9 ]

[ 4442-53-9 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 29668-43-7 ]
  • [ 4442-53-9 ]
YieldReaction ConditionsOperation in experiment
0.332 g
Stage #1: With aminosulfonic acid In water; acetone at 0 - 5℃; for 0.333333 h;
Stage #2: With sodium chlorite In water; acetone at 22 - 26℃; for 18 h;
A solution of 2,3-dihydrobenzo[b][l,4]dioxine-5-carbaldehyde (0.500 g, 3.04 mmol) in acetone (10 mL) was stirred at 0-5°C and aqueous solution of sulphamic acid (0.455 g, 4.5 mmol) was added. The reaction mass was stirred for 20 min. Then aqueous solution of sodium chlorite (0.421 g, 4.5 mmol) was added and the reaction was further continued at RT for 18 h. After completion of reaction, reaction mixture was concentrated under reduced pressure and reaction mass was quenched with water. Solid obtained was filtered off and vacuum dried to afford 0.332 g of desired product. 1H NMR (DMSO-de): δ 4.27 (s, 4H), 6.84 (t, J = 7.2 Hz, 1H), 7.02 (d, J = 7.8 Hz, 1H), 7.20 (d, J= 7.5 Hz, 1H), 12.5 (bs, 1H); MS [M+H]+: 181.12.
Reference: [1] Patent: WO2013/153535, 2013, A1, . Location in patent: Page/Page column 63
  • 2
  • [ 303-38-8 ]
  • [ 106-93-4 ]
  • [ 4442-53-9 ]
Reference: [1] Journal of Organic Chemistry, 1948, vol. 13, p. 489,493
[2] Patent: US5919814, 1999, A,
  • 3
  • [ 2411-83-8 ]
  • [ 4442-53-9 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 2, p. 635 - 644
[2] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 11, p. 2947 - 2954
[3] Patent: CN106905335, 2017, A,
  • 4
  • [ 303-38-8 ]
  • [ 4442-53-9 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2011, vol. 59, # 2, p. 635 - 644
[2] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 11, p. 2947 - 2954
[3] Patent: CN106905335, 2017, A,
  • 5
  • [ 24677-78-9 ]
  • [ 4442-53-9 ]
Reference: [1] Patent: WO2013/153535, 2013, A1,
  • 6
  • [ 493-09-4 ]
  • [ 124-38-9 ]
  • [ 4442-53-9 ]
  • [ 4442-54-0 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 92, p. 14360 - 14363
  • 7
  • [ 493-09-4 ]
  • [ 124-38-9 ]
  • [ 4442-53-9 ]
  • [ 4442-54-0 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 92, p. 14360 - 14363
  • 8
  • [ 4442-53-9 ]
  • [ 214894-89-0 ]
Reference: [1] Patent: WO2017/155909, 2017, A1,
[2] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 8, p. 1797 - 1809
  • 9
  • [ 4442-53-9 ]
  • [ 274910-19-9 ]
YieldReaction ConditionsOperation in experiment
99% With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 18 h; To a solution of 2,3-dihydrobenzo[£][l,4]dioxine-5-carboxylic acid (5.00 g, 28.0 mmol) in THF (150 mL) at 0 °C was added lithium aluminium hydride (2.13 g, 56.0 mmol) in small portions. The reaction mixture was stirred at 0 °C for 10 min and stirred for a further 18 h at r.t. Water (150 mL) was added to the reaction mixture which was extracted with EtOAc (2 x 100 mL). The combined organic layers were washed with brine (100 mL), dried over Na2S04, filtered and concentrated under reduced pressure to obtain 20 as yellow oil (3.22 g, 99percent). 1H NMR (CDC13) δ 6.87-6.79 (m, 3H), 4.66 (s, 2H), 4.32-4.30 (m, 2H), 4.28-4.25 (m, 2H), 2.19 (bs, 1H). Found: [M+H-18]=149.5
99% With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 18 h; 4.1.1.1. 6-Bromo-3-((2,3-dihydrobenzo[b][1,4]dioxin-5-yl)methyl)-2-methoxyquinoline (VI: Y = 2,3-O(CH2)2O–). To a solution of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylic acid (5.00 g, 28.0 mmol)in THF (150 mL) at 0 C was added lithium aluminium hydride(2.13 g, 56.0 mmol) in small portions. The reaction mixture wasstirred at 0 C for 10 min and stirred for a further 18 h at 20 C.Water (150 mL) was added to the reaction mixture which wasextracted with EtOAc (2 100 mL). The combined organic layerswere washed with brine (100 mL), dried over Na2SO4, filteredand concentrated under reduced pressure to obtain (2,3-dihydrobenzo[b][1,4]dioxin-5-yl)methanol as a yellow oil (3.22 g,99percent). 1H NMR (CDCl3, 400 MHz) d 6.87–6.79 (m, 3H), 4.66 (s, 2H),4.32–4.30 (m, 2H), 4.28–4.25 (m, 2H), 2.19 (bs, 1H). Found: [M+H-18] = 149.5.
Reference: [1] Patent: WO2017/155909, 2017, A1, . Location in patent: Paragraph 0075
[2] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 8, p. 1797 - 1809
  • 10
  • [ 4442-53-9 ]
  • [ 64-17-5 ]
  • [ 261767-10-6 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2014, vol. 62, # 11, p. 1110 - 1118
[2] Patent: CN103664910, 2017, B, . Location in patent: Paragraph 011
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4442-53-9 ]

Carboxylic Acids

Chemical Structure| 877-22-5

[ 877-22-5 ]

3-Methoxysalicylic acid

Similarity: 0.96

Chemical Structure| 5722-93-0

[ 5722-93-0 ]

2-Hydroxy-4,5-dimethoxybenzoic acid

Similarity: 0.94

Chemical Structure| 4442-54-0

[ 4442-54-0 ]

2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid

Similarity: 0.92

Chemical Structure| 25045-36-7

[ 25045-36-7 ]

2-Methoxy-5-methylbenzoic acid

Similarity: 0.92

Chemical Structure| 704-45-0

[ 704-45-0 ]

4-Methyl-2-methoxybenzoic acid

Similarity: 0.92

Related Parent Nucleus of
[ 4442-53-9 ]

Benzodioxans

Chemical Structure| 261767-10-6

[ 261767-10-6 ]

Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate

Similarity: 0.94

Chemical Structure| 4442-54-0

[ 4442-54-0 ]

2,3-Dihydro-1,4-benzodioxine-6-carboxylic acid

Similarity: 0.92

Chemical Structure| 29668-44-8

[ 29668-44-8 ]

2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde

Similarity: 0.80

Chemical Structure| 823225-66-7

[ 823225-66-7 ]

Methyl 8-bromo-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate

Similarity: 0.79

Chemical Structure| 2879-20-1

[ 2879-20-1 ]

1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone

Similarity: 0.74